Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6393 - 6400 of 11537 results
FDA Stays in the Spotlight with Drug Pricing Moves, but Could Be Facing Risk as UFA Bill Loses Attention
June 30, 2017| Blog| Viewpoint
Does The American Law Institute Have An Ethics Problem On Its Hands?
June 30, 2017| News
Payless, Creditors Reach Settlement on Significant Issues in Bankruptcy Plan
June 30, 2017| News
Drug Makers Not Off the Hook as States Continue to Take Action to Control Drug Prices
June 29, 2017| Blog| Viewpoint
Second Circuit Denies Latest Request for En Banc Review in Title VII Sexual Orientation Discrimination Case
June 29, 2017| Blog| Viewpoint
Massachusetts House & Senate Tackle Marijuana
June 28, 2017| Blog| Viewpoint
USCIS Introduces Redesigned I-485 Application Forms
June 28, 2017| Blog| Viewpoint
Extension of U.S. Patent and Trademark Office’s Cancer Immunotherapy Pilot Program
June 28, 2017| Blog| Viewpoint
News & Press Releases
Mintz Announces Partnership with Lineal | Amplify Suite Technology
November 19, 2024
Mintz has partnered with Lineal, a leader in legal technology and data review solutions to assist with client services delivery. The collaboration brings Lineal’s Amplify Suite—an advanced RelativityOne integration—into Mintz’s practice to enhance early data assessment (EDA), streamline modern data review, and manage strategic decision calls.
Mintz Advises Aspen Aerogels on $98M Follow-on Offering
November 19, 2024
Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.
Mintz Advises Charlesbank Capital Partners on Strategic Investment with IMPLAN Group
November 18, 2024
Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software.
Events
Podcasts
Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health
October 11, 2024| Podcast|
Health Law Diagnosed – Women Leaders in Health Care: The Emerging Role of AI in Health Care
March 22, 2024| Podcast|